Related Experiment Video
Updated: Jun 11, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.7K
TLR3 activation mediates partial epithelial-to-mesenchymal transition in human keratinocytes
Andrea M Schneider1, Robert P Feehan1, Mackenzie L Sennett1
1Department of Dermatology, Penn State Health Hershey Medical Center, Hershey, PA, USA.
Life Science Alliance
|September 30, 2024
Summary
Toll-like receptor 3 (TLR3) activation in human skin keratinocytes by UVB or poly(I:C) triggers epithelial-to-mesenchymal transition. This suggests TLR3 signaling influences skin development and regeneration beyond immunity.
Area of Science:
- Dermatology
- Immunology
- Cell Biology
Background:
- Toll-like receptor 3 (TLR3) is present in human skin keratinocytes.
- TLR3 plays a role in skin inflammation, development, and regeneration.
- Understanding TLR3's cellular response in keratinocytes is crucial.
Purpose of the Study:
- To investigate the cellular response of normal human keratinocytes to TLR3 activation.
- To examine the effects of both physiological (UVB) and synthetic (poly(I:C)) TLR3 activators.
Main Methods:
- Primary human keratinocytes were treated with UVB and poly(I:C).
- Morphological changes and gene expression related to epithelial-to-mesenchymal transition (EMT) were analyzed.
- Cell migration and invasion assays were performed.
Main Results:
- TLR3 activation by UVB or poly(I:C) induced significant changes in keratinocyte morphology.
- Key features of epithelial-to-mesenchymal transition (EMT) were observed, including increased gene expression, migration, and invasion.
- These changes indicate a role for TLR3 in regulating stem cell-like properties.
Conclusions:
- TLR3 signaling in keratinocytes promotes EMT, affecting cell migration and invasion.
- Beyond its immune function, TLR3 activation influences developmental programs in skin.
- These findings highlight TLR3's role in skin regeneration and stem cell regulation.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Receptor Tyrosine Kinases
12.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.4K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

